The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
B cells as therapeutic targets in SLE
Open accessAbstract
The use of B-cell targeted therapies for the treatment of systemic lupus erythematosus (SLE) has generated great interest owing to the multiple pathogenic roles carried out by B cells in this disease. Strong support for targeting B cells is provided by genetic, immunological and clinical observations that place these cells at the center of SLE pathogenesis, as initiating, amplifying and effector cells. Interest in targeting B cells has also been fostered by the successful use of similar interventions to treat other autoimmune diseases such as rheumatoid arthritis, and by the initial promise shown by B-cell depletion to treat SLE in early studies. Although the initial high enthusiasm has been tempered by negative results from phase III trials of the B-cell-depleting agent rituximab in SLE, renewed vigor should be instilled in the field by the convergence of the latest results using agents that inhibit B-cell-activating factor (BAFF, also known as BLyS and tumor necrosis factor ligand superfamily, member 13b), further analysis of data from trials using rituximab and greatly improved understanding of B-cell biology. Combined, the available information identifies several new avenues for the therapeutic targeting of B cells in SLE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Doreau, A., Belot, A., Bastid, J., Riche, B., Trescol-Biemont, M.-C., Ranchin, B., Fabien, N., Cochat, P., Pouteil-Noble, C., Trolliet, P., et al. (2009) · Nature Immunology · doi:10.1038/ni.1741 · Cited by 452
RetractedBortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
San Miguel, J. F., Schlag, R., Khuageva, N. K., Dimopoulos, M. A., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M. T., Palumbo, A., Samoilova, O. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801479 · Cited by 1,899
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
Blair, P. A., Noreña, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.009 · Cited by 1,574 · cited 1×
“Of notable interest, human transitional B cells also have an IL-10-mediated regulatory function, which, in preliminary studies, seems to be defective in patients with SLE”
BackgroundMerrill, J. T., Neuwelt, C. M., Wallace, D. J., Shanahan, J. C., Latinis, K. M., Oates, J. C., Utset, T. O., Gordon, C., Isenberg, D. A., Hsieh, H., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27233 · Cited by 1,409
Yanaba, K., Bouaziz, J.-D., Haas, K. M., Poe, J. C., Fujimoto, M., & Tedder, T. F. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.017 · Cited by 1,238
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Obeng, E. A., Carlson, L. M., Gutman, D. M., Harrington, W. J., Lee, K. P., & Boise, L. H. (2006) · Blood · doi:10.1182/blood-2005-08-3531 · Cited by 1,143
Christensen, S. R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R. A., & Shlomchik, M. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.013 · Cited by 1,090
Competence and competition: the challenge of becoming a long-lived plasma cell
Radbruch, A., Muehlinghaus, G., Luger, E. O., Inamine, A., Smith, K. G. C., Dörner, T., & Hiepe, F. (2006) · Nature Reviews Immunology · doi:10.1038/nri1886 · Cited by 1,030
Germinal-Center Organization and Cellular Dynamics
Allen, C. D. C., Okada, T., & Cyster, J. G. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.009 · Cited by 983
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
Matsushita, T., Yanaba, K., Bouaziz, J.-D., Fujimoto, M., & Tedder, T. F. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36030 · Cited by 913
Looney, R. J., Anolik, J. H., Campbell, D., Felgar, R. E., Young, F., Arend, L. J., Sloand, J. A., Rosenblatt, J., & Sanz, I. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20430 · Cited by 776
Self-citationHsu, H.-C., Yang, P., Wang, J., Wu, Q., Myers, R., Chen, J., Yi, J., Guentert, T., Tousson, A., Stanus, A. L., et al. (2008) · Nature Immunology · doi:10.1038/ni1552 · Cited by 716
Duddy, M., Niino, M., Adatia, F., Hebert, S., Freedman, M., Atkins, H., Kim, H. J., & Bar-Or, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6092 · Cited by 653
Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus
Odendahl, M., Jacobi, A., Hansen, A., Feist, E., Hiepe, F., Burmester, G. R., Lipsky, P. E., Radbruch, A., & Dörner, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5970 · Cited by 642
Wei, C., Anolik, J., Cappione, A., Zheng, B., Pugh-Bernard, A., Brooks, J., Lee, E.-H., Milner, E. C. B., & Sanz, I. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6624 · Cited by 604
Self-citationFollicular helper T cells are required for systemic autoimmunity
Linterman, M. A., Rigby, R. J., Wong, R. K., Yu, D., Brink, R., Cannons, J. L., Schwartzberg, P. L., Cook, M. C., Walters, G. D., & Vinuesa, C. G. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081886 · Cited by 587
Wallace, D. J., Stohl, W., Furie, R. A., Lisse, J. R., McKay, J. D., Merrill, J. T., Petri, M. A., Ginzler, E. M., Chatham, W. W., McCune, W. J., et al. (2009) · Arthritis Care & Research · doi:10.1002/art.24699 · Cited by 585
Neubert, K., Meister, S., Moser, K., Weisel, F., Maseda, D., Amann, K., Wiethe, C., Winkler, T. H., Kalden, J. R., Manz, R. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1763 · Cited by 584
Reduced Competitiveness of Autoantigen-Engaged B Cells due to Increased Dependence on BAFF
Lesley, R., Xu, Y., Kalled, S. L., Hess, D. M., Schwab, S. R., Shu, H.-B., & Cyster, J. G. (2004) · Immunity · doi:10.1016/s1074-7613(04)00079-2 · Cited by 577
Novel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis
Evans, J. G., Chavez-Rueda, K. A., Eddaoudi, A., Meyer-Bahlburg, A., Rawlings, D. J., Ehrenstein, M. R., & Mauri, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7868 · Cited by 570
Cytokine-producing B lymphocytes-key regulators of immunity
Lund, F. E. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.003 · Cited by 556
Ngo, V. N., Korner, H., Gunn, M. D., Schmidt, K. N., Sean Riminton, D., Cooper, M. D., Browning, J. L., Sedgwick, J. D., & Cyster, J. G. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.403 · Cited by 553
BAFF selectively enhances the survival of plasmablasts generated from human memory B cells
Avery, D. T., Kalled, S. L., Ellyard, J. I., Ambrose, C., Bixler, S. A., Thien, M., Brink, R., Mackay, F., Hodgkin, P. D., & Tangye, S. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18025 · Cited by 509
Illei, G. G., Shirota, Y., Yarboro, C. H., Daruwalla, J., Tackey, E., Takada, K., Fleisher, T., Balow, J. E., & Lipsky, P. E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27221 · Cited by 507
Dysregulation of germinal centres in autoimmune disease
Vinuesa, C. G., Sanz, I., & Cook, M. C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2637 · Cited by 464
Self-citationRituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus
Anolik, J. H., Barnard, J., Cappione, A., Pugh‐Bernard, A. E., Felgar, R. E., Looney, R. J., & Sanz, I. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20592 · Cited by 456
Self-citationTLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity
Lampropoulou, V., Hoehlig, K., Roch, T., Neves, P., Gómez, E. C., Sweenie, C. H., Hao, Y., Freitas, A. A., Steinhoff, U., Anderton, S. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4763 · Cited by 436
Petri, M., Stohl, W., Chatham, W., McCune, W. J., Chevrier, M., Ryel, J., Recta, V., Zhong, J., & Freimuth, W. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23678 · Cited by 428
Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice
Hu, C.-Y., Rodriguez-Pinto, D., Du, W., Ahuja, A., Henegariu, O., Wong, F. S., Shlomchik, M. J., & Wen, L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32405 · Cited by 426
Tian, J., Zekzer, D., Hanssen, L., Lu, Y., Olcott, A., & Kaufman, D. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.1081 · Cited by 412
Avery, D. T., Deenick, E. K., Ma, C. S., Suryani, S., Simpson, N., Chew, G. Y., Chan, T. D., Palendira, U., Bustamante, J., Boisson-Dupuis, S., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091706 · Cited by 409
PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond?
Rommel, C., Camps, M., & Ji, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2036 · Cited by 398
Phenotypic and functional heterogeneity of human memory B cells
Sanz, I., Wei, C., Lee, F. E.-H., & Anolik, J. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.12.006 · Cited by 361
Self-citationRecent insights into the genetic basis of systemic lupus erythematosus
Moser, K. L., Kelly, J. A., Lessard, C. J., & Harley, J. B. (2009) · Genes & Immunity · doi:10.1038/gene.2009.39 · Cited by 352
Plasmacytoid Dendritic Cells Control TLR7 Sensitivity of Naive B Cells via Type I IFN
Bekeredjian-Ding, I. B., Wagner, M., Hornung, V., Giese, T., Schnurr, M., Endres, S., & Hartmann, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4043 · Cited by 349
Anolik, J. H., Barnard, J., Owen, T., Zheng, B., Kemshetti, S., Looney, R. J., & Sanz, I. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22810 · Cited by 333
Self-citationB‐lymphocyte contributions to human autoimmune disease
Yanaba, K., Bouaziz, J., Matsushita, T., Magro, C. M., St.Clair, E. W., & Tedder, T. F. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00646.x · Cited by 326
PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus
Barber, D. F., Bartolomé, A., Hernandez, C., Flores, J. M., Redondo, C., Fernandez-Arias, C., Camps, M., Rückle, T., Schwarz, M. K., Rodríguez, S., et al. (2005) · Nature Medicine · doi:10.1038/nm1291 · Cited by 310
Novel Human Transitional B Cell Populations Revealed by B Cell Depletion Therapy
Palanichamy, A., Barnard, J., Zheng, B., Owen, T., Quach, T., Wei, C., Looney, R. J., Sanz, I., & Anolik, J. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801859 · Cited by 300
Self-citationFcγRIIb controls bone marrow plasma cell persistence and apoptosis
Xiang, Z., Cutler, A. J., Brownlie, R. J., Fairfax, K., Lawlor, K. E., Severinson, E., Walker, E. U., Manz, R. A., Tarlinton, D. M., & Smith, K. G. C. (2007) · Nature Immunology · doi:10.1038/ni1440 · Cited by 296
Not always the bad guys: B cells as regulators of autoimmune pathology
Fillatreau, S., Gray, D., & Anderton, S. M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2315 · Cited by 295
Dall'Era, M., Chakravarty, E., Wallace, D., Genovese, M., Weisman, M., Kavanaugh, A., Kalunian, K., Dhar, P., Vincent, E., Pena‐Rossi, C., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23047 · Cited by 294
Blair, P. A., Chavez-Rueda, K. A., Evans, J. G., Shlomchik, M. J., Eddaoudi, A., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803052 · Cited by 291
Jacobi, A. M., Reiter, K., Mackay, M., Aranow, C., Hiepe, F., Radbruch, A., Hansen, A., Burmester, G., Diamond, B., Lipsky, P. E., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23498 · Cited by 289
Barrat, F. J., Meeker, T., Chan, J. H., Guiducci, C., & Coffman, R. L. (2007) · European Journal of Immunology · doi:10.1002/eji.200737815 · Cited by 284
Yao, Y., Richman, L., Higgs, B. W., Morehouse, C. A., de los Reyes, M., Brohawn, P., Zhang, J., White, B., Coyle, A. J., Kiener, P. A., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24557 · Cited by 284
CXCR4: chemokine receptor extraordinaire
Murdoch, C. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17715.x · Cited by 284
Lu, T. Y. ‐., Ng, K. P., Cambridge, G., Leandro, M. J., Edwards, J. C. W., Ehrenstein, M., & Isenberg, D. A. (2009) · Arthritis Care & Research · doi:10.1002/art.24341 · Cited by 275
IFN‐α/β enhances BCR‐dependent B cell responses
Braun, D., Caramalho, I., & Demengeot, J. (2002) · International Immunology · doi:10.1093/intimm/14.4.411 · Cited by 268
B-Cell–Depleting Induction Therapy and Acute Cellular Rejection
Clatworthy, M. R., Watson, C. J. E., Plotnek, G., Bardsley, V., Chaudhry, A. N., Bradley, J. A., & Smith, K. G. C. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0808481 · Cited by 257
Selective dysregulation of the FcγIIB receptor on memory B cells in SLE
Mackay, M., Stanevsky, A., Wang, T., Aranow, C., Li, M., Koenig, S., Ravetch, J. V., & Diamond, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051503 · Cited by 252
Jacobi, A. M., Huang, W., Wang, T., Freimuth, W., Sanz, I., Furie, R., Mackay, M., Aranow, C., Diamond, B., & Davidson, A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27189 · Cited by 243
Self-citationDevelopment of psoriasis after B cell depletion with rituximab
Dass, S., Vital, E. M., & Emery, P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22811 · Cited by 237
LENERT, P., BRUMMEL, R., Field, E. H., & ASHMAN, R. F. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-0355-6 · Cited by 234
Lövgren, T., Eloranta, M., Kastner, B., Wahren‐Herlenius, M., Alm, G. V., & Rönnblom, L. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21893 · Cited by 232
Moir, S., Malaspina, A., Pickeral, O. K., Donoghue, E. T., Vasquez, J., Miller, N. J., Krishnan, S. R., Planta, M. A., Turney, J. F., Justement, J. S., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032236 · Cited by 227
Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis
Dass, S., Rawstron, A. C., Vital, E. M., Henshaw, K., McGonagle, D., & Emery, P. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23902 · Cited by 210
Albert, D., Dunham, J., Khan, S., Stansberry, J., Kolasinski, S., Tsai, D., Pullman-Mooar, S., Barnack, F., Striebich, C., Looney, R. J., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.083162 · Cited by 209
Development of TLR inhibitors for the treatment of autoimmune diseases
Barrat, F. J., & Coffman, R. L. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00630.x · Cited by 206
Type I IFN Protects Against Murine Lupus
Hron, J. D., & Peng, S. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.2134 · Cited by 201
Yellin, M., Paliienko, I., Balanescu, A., Ter‐Vartanian, S., Tseluyko, V., Xu, L., Tao, X., Cardarelli, P. M., LeBlanc, H., Nichol, G., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34330 · Cited by 194
Cambridge, G., Isenberg, D. A., Edwards, J. C. W., Leandro, M. J., Migone, T.-S., Teodorescu, M., & Stohl, W. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.079418 · Cited by 193
BAFF: a local and systemic target in autoimmune diseases
Moisini, I., & Davidson, A. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.04007.x · Cited by 193
Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus
Sawalha, A. H., Kaufman, K. M., Kelly, J. A., Adler, A. J., Aberle, T., Kilpatrick, J., Wakeland, E. K., Li, Q.-Z., Wandstrat, A. E., Karp, D. R., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.075424 · Cited by 189
Wei, B., Velazquez, P., Turovskaya, O., Spricher, K., Aranda, R., Kronenberg, M., Birnbaumer, L., & Braun, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409449102 · Cited by 176
Bahjat, F. R., Pine, P. R., Reitsma, A., Cassafer, G., Baluom, M., Grillo, S., Chang, B., Zhao, F. F., Payan, D. G., Grossbard, E. B., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23428 · Cited by 171
Ettinger, R., Sims, G. P., Robbins, R., Withers, D., Fischer, R. T., Grammer, A. C., Kuchen, S., & Lipsky, P. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2872 · Cited by 167
Gaspal, F. M. C., Kim, M.-Y., McConnell, F. M., Raykundalia, C., Bekiaris, V., & Lane, P. J. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.3891 · Cited by 165
The effect of anti‐CD40 ligand antibody on B cells in human systemic lupus erythematosus
Huang, W., Sinha, J., Newman, J., Reddy, B., Budhai, L., Furie, R., Vaishnaw, A., & Davidson, A. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10273 · Cited by 165
Reciprocal generation of Th1/Th17 and Treg cells by B1 and B2 B cells
Zhong, X., Gao, W., Degauque, N., Bai, C., Lu, Y., Kenny, J., Oukka, M., Strom, T. B., & Rothstein, T. L. (2007) · European Journal of Immunology · doi:10.1002/eji.200737296 · Cited by 163
Rafei, M., Hsieh, J., Zehntner, S. P., Li, M., Forner, K., Birman, E., Boivin, M., Young, Y. K., Perreault, C., & Galipeau, J. (2009) · Nature Medicine · doi:10.1038/nm.2003 · Cited by 157
Anolik, J. H., Ravikumar, R., Barnard, J., Owen, T., Almudevar, A., MILNER, E. C. B., Miller, C. H., Dutcher, P. O., Hadley, J. A., & Sanz, I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.688 · Cited by 156
Self-citationDhodapkar, K. M., Banerjee, D. K., Connolly, J., Kukreja, A., Matayeva, E., Veri, M. C., Ravetch, J. V., Steinman, R. M., & Dhodapkar, M. V. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062545 · Cited by 141
Barcellos, L. F., May, S. L., Ramsay, P. P., Quach, H. L., Lane, J. A., Nititham, J., Noble, J. A., Taylor, K. E., Quach, D. L., Chung, S. A., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000696 · Cited by 131 · cited 1×
“Notably, all B-cell-targeting interventions will have to contend with one of the main obstacles faced in the treatment of SLE—namely, the high degree of disease diversity, which may be mediated at least in part by genetic heterogeneity”
BackgroundJacobi, A. M., Goldenberg, D. M., Hiepe, F., Radbruch, A., Burmester, G. R., & Dörner, T. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.075762 · Cited by 127
Nanki, T., Takada, K., Komano, Y., Morio, T., Kanegane, H., Nakajima, A., Lipsky, P. E., & Miyasaka, N. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2823 · Cited by 121
Yazawa, N., Hamaguchi, Y., Poe, J. C., & Tedder, T. F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505539102 · Cited by 115
Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production
Kalled, S. L. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.06.002 · Cited by 97
Cutting Edge: Primary B Lymphocytes Preferentially Expand Allogeneic FoxP3+ CD4 T Cells
Chen, X., & Jensen, P. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2046 · Cited by 80
B Cells and Immunological Tolerance
Manjarrez‐Orduño, N., Quách, T. D., & Sanz, I. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.240 · Cited by 80
Self-citationThibault, D. L., Graham, K. L., Lee, L. Y., Balboni, I., Hertzog, P. J., & Utz, P. J. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2771 · Cited by 79
CXCL13 neutralization reduces the severity of collagen‐induced arthritis
Zheng, B. Q., Özen, Z., Zhang, X., Silva, S. D., Marinova, E., Guo, L., Wansley, D. L., Huston, D. P., West, M. R., & Han, S. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20768 · Cited by 74
IFN-α amplifies human naïve B cell TLR-9-mediated activation and Ig production
Giordani, L., Sanchez, M., Libri, I., Quaranta, M. G., Mattioli, B., & Viora, M. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0908560 · Cited by 72
Grammer, A. C., & Lipsky, P. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10287 · Cited by 62
van der Heijden, J. W., Oerlemans, R., Lems, W. F., Scheper, R. J., Dijkmans, B. A. C., & Jansen, G. (2009) · PubMed · Cited by 62
B Cell Depletion with Anti-CD79 mAbs Ameliorates Autoimmune Disease in MRL/ lpr Mice
Li, Y., Chen, F., Putt, M., Koo, Y., Madaio, M. P., Cambier, J. C., Cohen, P. L., & Eisenberg, R. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.2961 · Cited by 57
FcγRIIB as a modulator of autoimmune disease susceptibility
Tarasenko, T., Dean, J. A., & Bolland, S. M. (2007) · Autoimmunity · doi:10.1080/08916930701464665 · Cited by 56
Leandro, M. J., & de la Torre, I. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03978.x · Cited by 52
Ghosh, D., & Tsokos, G. C. (2009) · Autoimmunity · doi:10.3109/08916930903374717 · Cited by 50
How does B cell depletion therapy work, and how can it be improved?
Clark, E. A., & Ledbetter, J. A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.042507 · Cited by 38
Deficiency of type I interferon contributes to Sle2‐associated component lupus phenotypes
Li, J., Liu, Y., Xie, C., Zhu, J., Kreska, D., Morel, L. M., & Mohan, C. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21307 · Cited by 37
Xie, C., Patel, R. K., Wu, T., Zhu, J., Henry, T., Bhaskarabhatla, M., Samudrala, R., Tus, K., Gong, Y., Zhou, H. F., et al. (2007) · International Immunology · doi:10.1093/intimm/dxm017 · Cited by 37
Wallace, D. J., Houssiau, F., Hobbs, K., Strand, V., Tak, P. P., Wegener, W. A., Kelley, L., & Barry, A. (2008) · Arthritis & Rheumatism · Cited by 26
The conundrum of B cell depletion in SLE
Sanz, I. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.100 · Cited by 21
Self-citation
Cited by
The non-canonical NF-κB pathway in immunity and inflammation
Sun, S.-C. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.52 · Cited by 1,891
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
Banchereau, R., Hong, S., Cantarel, B., Baldwin, N., Baisch, J., Edens, M., Cepika, A.-M., Acs, P., Turner, J., Anguiano, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.03.008 · Cited by 731
Tipton, C. M., Fucile, C. F., Darce, J., Chida, A., Ichikawa, T., Gregoretti, I., Schieferl, S., Hom, J., Jenks, S., Feldman, R. J., et al. (2015) · Nature Immunology · doi:10.1038/ni.3175 · Cited by 581
Self-citationInhibition of microRNA function by antimiR oligonucleotides
Stenvang, J., Petri, A., Lindow, M., Obad, S., & Kauppinen, S. (2012) · Silence · doi:10.1186/1758-907x-3-1 · Cited by 560
Murine Models of Systemic Lupus Erythematosus
Perry, D., Sang, A., Yin, Y., Zheng, Y.-Y., & Morel, L. (2011) · BioMed Research International · doi:10.1155/2011/271694 · Cited by 378
Metadata
- Authors
- Sanz, I., & Lee, F. E.-H.
- Venue
- Nature Reviews Rheumatology
- Published
- 2010-06
- Volume
- 6
- Issue
- 6
- Pages
- 326-337
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- OpenAlex
- W2033418370
- Cited by
- 261
- References
- 95
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.